Jin Ge, Founder and CEO of Rendong Medicine, Confirms Participation in the 3rd International Medical Device Innovation Summit
In the fields of in vitro diagnostics, high-value consumables, and rehabilitation equipment, how can the correct development path be identified through upstream and downstream supply chain collaboration, upgrading of technological and industrial foundations, and coordinated interaction of key industry development factors?June 22, 2021，2021 The 3rd International Summit on Medical Device InnovationScheduled forNanjing · Gaochunheld. This event will center on“Intelligent Manufacturing as the Foundation, Collaborative Innovation”centered on key themes, the event will bring together the most active medical device innovators, listed companies, financial institutions, and healthcare providers from China and abroad through formats such as the Medical Device Vitality Ranking, closed-door government-enterprise meetings, overseas live connections, keynote speeches, and roundtable discussions, creating a premier offline gathering for the medical device industry.
This event was hosted by the Nanjing New Medicine and Life Health Industry Chain Working Task Force and the People’s Government of Gaochun District, Nanjing; organized by the Office of the Innovation Committee of the CPC Gaochun District Committee and VCBeat; and co-organized by Jiangsu Gaochun Economic Development Zone and Jiangsu Gaochun High-Tech Industrial Development Zone.
Jin Ge, Founder and CEO of Rendong Medicine, Confirmed to Attend the 3rd International Summit on Medical Device Innovation, and will publish related insights.
Click the image to register
Jin Ge,Founder and CEO of Rendong Medical
Ms. Jin Ge, CEO of Rendong Medicine Group, 6th Cohort Student at Hupan University, and EMBA graduate of CEIBS. She is currently the Founder and Chief Executive Officer of Rendong Medicine Group, and also serves as a member of the Smart Healthcare Expert Committee and the Patient Education Expert Committee of the Chinese Society of Clinical Oncology (CSCO), Head of the External Liaison Department of the China IVD and Precision Medicine Industry & Investment Alliance, Distinguished Lecturer at Harbin Medical University, and Founder of the Baichuan Public Welfare Foundation.
Rendong Medicine was established in2015[Year], it is a comprehensive big-data medical platform integrating industry, academia, research, and application, specializing in the integrated precision immuno-oncology diagnosis and treatment. As a leading enterprise in precision immuno-oncology diagnosis and treatment, the company, based on collaborations with the Chinese Academy of Sciences, the Chinese Academy of Medical Sciences, Peking Union Medical College, Peking University, the University of Pittsburgh, and Max-Multinational and interdisciplinary research teams, including the Max Planck Institute, have accumulated extensive data through academic collaborations with clinical experts. By leveraging artificial intelligence and big data analytics, they have established evaluation systems and standards for precision immuno-oncology therapy and developed immune therapy-related biomarkers. Adhering to the philosophy that service creates value, these teams have built a robust integrated ecosystem encompassing industry, academia, research, and clinical application, providing comprehensive solutions for the integrated diagnosis and treatment of cancer via precision immunotherapy.
Rendong Medicine is committed to extending the benefits of tumor immunotherapy to a broader population. Leveraging its proprietary genetic testing technologies and a multi-dimensional, multi-omics testing platform, the company has launched the “Tumor Immunology Ark Project.” By integrating clinical phenotype data with follow-up data on drug efficacy, Rendong Medicine aims to connect genetic data, clinical follow-up data, and medication data, thereby establishing a tripartite, closed-loop system for precision diagnosis and treatment. The company is dedicated to exploring evaluation standards and systems for tumor immunotherapy diagnosis and treatment, ultimately achieving clinical translation and assisting clinicians and patients in formulating precise diagnostic and therapeutic regimens.
At the summit, we have specially invitedNobel Laureate in Physiology or Medicine, Academician of the Chinese Academy of Sciences and the Chinese Academy of EngineeringRenowned experts will share cutting-edge domestic and international technologies and frontier medical advancements, focusing on medical development amidst technological transformation, and redefining the evolutionary logic of technology and innovative thinking in the industry.
Senior executives from leading medical device companies, outstanding innovative entrepreneurs, senior directors of innovation departments, and seasoned investors will focus on “"The Growth Curve of the IVD Industry in the Post-Pandemic Era," "High-Value Consumables under Domestic Substitution and Volume-Based Procurement," and "Innovation in Rehabilitation Products and Application Scenarios amid Population Aging"Conduct in-depth discussions along three main lines.
Currently, the 2014 Nobel Prize laureate in Physiology or Medicine,Edvard MoserConfirmed participation in this event and will deliver a presentation on"How the Brain Works: A Spatial Systems Approach to Decoding Computation in the Brain"Related Sharing.Academician of the Chinese Academy of Sciences and neurosurgery expert Zhao Jizong, Academician of the Chinese Academy of Engineering Zhang ZhiyuanAll have confirmed their attendance and will deliver relevant presentations.
The 2021 List of Innovative Vitality in Medical Devices is part of the regular series of the Top 100 Future Healthcare Companies list. VCBeat, with industrial research as its foundation, focuses on innovative development, technological transformation, and policy iterations in the medical device sector, while identifying high-growth innovative medical device companies fromIn Vitro Diagnostics (Digital PCR Category)、High-Value Consumables (Cardiovascular Intervention)、Rehabilitation Equipment (Rehabilitation Robotics)The Top Three Lists Based on Fundamental Dimensions and the List of Cutting-Edge Medical Device Technologies Selected the 2021 Innovative and Vital Enterprises in the Medical Device Industry.
The 2021 Medical Device Innovation Vitality List will be announced at the 3rd International Summit on Medical Device Innovation in 2021., and will be promoted through VCBeat’s online media matrix.
Some Confirmed Guests
(Listed in the order of guest speakers)
Edward Moser, the 2014 Nobel Prize in Physiology or Medicine
Zhao Jizong, Academician of the Chinese Academy of Sciences and neurosurgeon
Zhang Zhiyuan, Academician of the Chinese Academy of Engineering
Deng Jianmin, Senior Vice President, Global, and General Manager, Greater China, BD (Becton, Dickinson and Company)
Kang Keren, Senior Vice President of Wondfo Biotech
Shen Qin, Partner at Shengyu Investment
Yang Bin, Director of the Center for Smart Health, Institute for Precision Medicine, Tsinghua University
Jin Ge, Founder and CEO of Rendong Medical
Guo Feng, Founder of Zhenzhun Bio
Peng Yifei, General Manager of Tigermed Jietong
Jin Lei, CEO of BaiRen Medical
Wang Jinhe, Vice President of Johnson & Johnson Medical
Zhang Bing, Director of Market Access and Government Affairs at Double Medical
Yang He, CEO of Weimai Medical
Geng Yan, Chairman of Yizheng Medical
Wang Jun, Partner at Puhua Capital
Yu Jurong, Partner at Heju Yinuo
Zhu Zhiyang, Chairman of Suruiqi Medical
Xu Junhua, Founder of Aomei Health
Xu Changjun, CEO of Julu Medical
Yang Zhihao, Vice President of Fourier Intelligence
Zhang Jiyu, COO of Chengtian Technology
More guests are being confirmed...
You Are Only One Ticket Away from Industry Titans
Time:Tuesday, June 22, 2021
Location:China · Nanjing
Conference Official Website:https://vcbeat.top/Forum/summitIndex3
Click the image above or scan the QR code to register for free